adamantane has been researched along with Teratocarcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barzago, MM; Carminati, P; Dallavalle, S; Diomede, L; Fratelli, M; Garattini, E; Giannì, M; Kurosaki, M; Merlini, L; Parrella, E; Pisano, C; Raska, I; Rochette-Egly, C; Tavecchio, M; Terao, M | 1 |
1 other study(ies) available for adamantane and Teratocarcinoma
Article | Year |
---|---|
Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamm
Topics: Adamantane; Animals; Antineoplastic Agents; Calcium; Cell Death; Cell Differentiation; Cells, Cultured; Chlorocebus aethiops; Cinnamates; COS Cells; Cytosol; Disease Models, Animal; G2 Phase; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, SCID; Mitosis; Receptors, Retinoic Acid; Retinoic Acid Receptor gamma; Retinoids; RNA, Messenger; Teratocarcinoma; Tretinoin | 2006 |